ISODEL™ Amino acid based polymer diversity for innovative therapies
Access to new polypeptide excipients and polymer conjugates
GMP Polymers and copolymers based on various polyamino acids such as: Poly-L-Lysine, Poly-L-Glutamic acid, Polysarcosine... .
From R&D to GMP large scale manufacturing
Why a polyaminoacid based delivery technology?
- Growing interest for advanced biomedecines
- Biocompatibility and biodegradability
- Chemical & Architectural Versatility of Polyamino acids & polypeptides
- Many therapeutic areas: Immunotherapy, Oncology, Gene Therapy, Inflammatory, Neurodegenerative, Infectious, Diagnosis, Skin care…
Which delivery technology?
A biomaterial toolbox for various Nanotechnologies and Drug Conjugates
What polymeric structure?
What is the value of our services?
PMC Isochem: a CDMO for GMP polyamino acids integrated in strategic monomers (NCAs)
- Standard and customized polyamino acids and functionalization
- Development and characterization
- Scale-up and supply of preclinical and clinical batches
- Commercial supply
Expertise and capability
- Highly talented & multidisciplinary R&D team with academic connection
- Full equipped infrastructures and network to access cutting-edge technologies
- Custom made PAA design for your application supported by integrated NCA supply and development for GMP Polymers and copolymers based on various polyamino acids such as: Poly-L-Lysine, Poly-L-Glutamic acid, Polysarcosine...
- Lean approach to provide a faster, cheaper and better solution
- Allow you to save time, cost and risk
- IP portfolio and proprietary PAA systems to grow your business
- Flexible and creative business development team